Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Two-Drug Regimen of Dolutegravir Plus Lamivudine (DTG+ 3TC) Is Non-Inferior to Dolutegravir Plus Tenofovir/Emtricitabine (DTG+ TDF/FTC) at 48 Weeks in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: Subgroup Analyses in the GEMINI Studies
SURASADI KADHA (AN AYURVEDIC DECOCTION)-A SAFE AND EFFECTIVE FORMULATION IN TREATMENT OF COVID-19: A SINGLE-CENTERED, RETROSPECTIVE, OBSERVATIONAL STUDY
A Structured Review of Approaches for Establishing and Evaluating Clinical Relevance of Drug Interactions in Patients with Hepatitis C Virus Genotype 1